Dr. Lars Knutsen is a medicinal chemistry expert for CNS drugs. Dr. Knutsen was involved in development of 8 new chemical entities (NCEs) of which 6 entered clinical trials. He played a key role in development of anticonvulsant drug, Irdabisant (marketed worldwide as Gabitrilā¢).
Sign up to view 0 direct reports
Get started